BioGX

Apr

BioGX Launches Four CE-marked IVD Assays at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

VIENNA, April 24, 2017 /PRNewswire/ -- BioGX, a Birmingham Alabama based molecular diagnostics company, announced the launch of four additional CE-IVD infectious disease tests at the 27th...

Apr

Announcing the establishment of BioGX EU

BIRMINGHAM, Ala., April 21, 2017 /PRNewswire/ -- BioGX, a developer and manufacturer of molecular diagnostics CE-IVD tests has announced the establishment of European operations based in...

Mar

BioGX receives 2017 Governor's Trade Excellence Award

Montgomery, AL, March 8, 2017 – BioGX was honored as one of eight (8) companies selected as a 2017 Governor’s Trade Excellence Awards recipient during a ceremony at the state Capitol in...

Nov

BioGX Sample-Ready TM Technology Selected by NASA for Genetic Analysis Aboard the International Space Station

BIRMINGHAM, Ala., November 10, 2016 -- BioGX announced its Sample-Ready TM lyophilized qPCR technology was selected by the NASA WetLab-2 program to conduct genetic analysis aboard the...

What's New at BioGX

BioGX Launches Four CE-marked IVD Assays at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Announcing the establishment of BioGX EU

BioGX receives 2017 Governor's Trade Excellence Award

BioGX Sample-Ready TM Technology Selected by NASA for Genetic Analysis Aboard the International Space Station

There is currently no news to display